The DNA Rx. Advances in genetics give physicians ability to tailor drugs to patients' unique makeup.
Thanks to the recently completed first draft of the human genome map, the potential for advances in medical science seems endless. That's especially true in pharmacogenomics, with futuristic-sounding drugs and screening tests already available. William Evans (left), chairman of pharmaceutical science at St. Jude Children's Research Hospital, Memphis, Tenn., developed one of only a few pharmacogenomic applications available so far.
Becker
C
C
D017046:Cost Savings; D016503:Drug Delivery Systems; D004345:Drug Industry; D004798:Enzymes / Q000172:deficiency / Q000378:metabolism; D016045:Human Genome Project; D006801:Humans; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects; D010597:Pharmacogenetics / Q000191:economics / Q000639:trends*; D017422:Sequence Analysis, DNA; D014481:United States
D004798:Enzymes; D015122:Mercaptopurine